White Paper
Controlling Cancer Care: The Expansion of Formulary Exclusions in Oncology
Aug 26, 2022
As national payers have expanded their use of formulary exclusions for Oncology treatments, manufacturers will need to place additional focus on their oncology portfolio’s access strategy. This paper expands upon previous research by incorporating National Comprehensive Cancer Network (NCCN) guidelines and IQVIA’s longitudinal claims data.
Related solutions
Commercial Solutions
Data, AI, and expertise empower Commercial Solutions to optimize strategy, accelerate market access, and maximize brand performance.
Market Access
Gain high value access and increase the profitability of your brands